Khaled A M Abouzid Selected Research

Khaled A M Abouzid Research Topics

Disease

33	Neoplasms (Cancer) 03/2024 - 04/2014
6	Breast Neoplasms (Breast Cancer) 02/2023 - 12/2020
3	Carcinoma (Carcinomatosis) 03/2019 - 01/2018
2	Colonic Neoplasms (Colon Cancer) 01/2022 - 01/2013
2	Pancreatic Neoplasms (Pancreatic Cancer) 08/2020 - 01/2020
2	Hepatocellular Carcinoma (Hepatoma) 03/2019 - 05/2013
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2023
1	Leukemia 06/2023
1	Melanoma (Melanoma, Malignant) 06/2023
1	Kidney Neoplasms (Kidney Cancer) 06/2023
1	Endometrial Neoplasms (Endometrial Cancer) 01/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Necrosis 12/2021
1	COVID-19 08/2021
1	Inflammation (Inflammations) 12/2020
1	Neoplasm Metastasis (Metastasis) 12/2020
1	Prostatic Neoplasms (Prostate Cancer) 08/2020
1	Carcinogenesis 04/2020
1	Infections 01/2020
1	Adenocarcinoma 03/2019
1	Ascites 01/2018

Drug/Important Bio-Agent (IBA)

7	pyrimidineIBA 06/2023 - 01/2018
6	Phosphotransferases (Kinase)IBA 12/2022 - 04/2014
5	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 03/2019 - 04/2016
4	EnzymesIBA 01/2022 - 03/2019
4	ErbB Receptors (EGF Receptor)IBA 01/2018 - 08/2016
3	Gefitinib (Iressa)FDA Link 11/2019 - 12/2017
2	Proteins (Proteins, Gene)FDA Link 02/2023 - 04/2022
2	Glucose (Dextrose)FDA LinkGeneric 02/2023 - 04/2022
2	HexosesIBA 02/2023 - 04/2022
2	FructoseIBA 02/2023 - 04/2022
2	benzimidazoleIBA 12/2022 - 01/2022
2	Cytotoxins (Cytolysins)IBA 12/2022 - 11/2017
2	Tamoxifen FDA LinkGeneric 01/2022 - 12/2020
2	Histone Deacetylase InhibitorsIBA 12/2021 - 01/2018
2	Caspase 3 (Caspase-3)IBA 08/2020 - 01/2019
2	Oncogene Proteins (Oncogene Protein)IBA 04/2020 - 11/2019
2	human ERBB2 proteinIBA 01/2018 - 11/2016
1	KetonesIBA 03/2024
1	Protein Isoforms (Isoforms)IBA 01/2024
1	PiperazineIBA 06/2023
1	acetamideIBA 06/2023
1	Monosaccharide Transport ProteinsIBA 02/2023
1	LipidsIBA 12/2022
1	Antineoplastic Agents (Antineoplastics)IBA 12/2022
1	BenzimidazolesIBA 12/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2022
1	Biomarkers (Surrogate Marker)IBA 04/2022
1	6-deoxy-6-fluoro-D-fructoseIBA 04/2022
1	Messenger RNA (mRNA)IBA 04/2022
1	Membrane Transport Proteins (Biological Pump)IBA 04/2022
1	ChalconesIBA 03/2022
1	Selective Estrogen Receptor Modulators (SERM)IBA 01/2022
1	SolutionsIBA 01/2022
1	4-nitrophenylIBA 01/2022
1	fms-Like Tyrosine Kinase 3IBA 01/2022
1	Estrogens (Estrogen)FDA Link 01/2022
1	Histones (Histone)IBA 12/2021
1	indolin-2-oneIBA 12/2021
1	thienopyrimidineIBA 12/2021
1	Hydroxamic Acids (Hydroxamic Acid)IBA 12/2021
1	Aurora Kinase BIBA 12/2021
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021
1	Urea (Carbamide)FDA LinkGeneric 12/2020
1	Dinoprostone (PGE2)FDA Link 12/2020
1	Interleukin-6 (Interleukin 6)IBA 12/2020
1	Annexin A5IBA 08/2020
1	Fluorescein (Funduscein)FDA LinkGeneric 08/2020
1	isothiocyanic acidIBA 08/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	amuvatinibIBA 01/2020
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2020
1	PyrimidinesIBA 01/2020
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2019
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 11/2019
1	LigandsIBA 11/2019
1	QuinoxalinesIBA 03/2019
1	Sorafenib (BAY 43-9006)FDA Link 01/2019
1	AntioxidantsIBA 09/2018
1	pyrrolopyrimidineIBA 09/2018
1	Lapatinib (GW572016)FDA Link 07/2018
1	osimertinibIBA 12/2017
1	Anti-Infective Agents (Microbicides)IBA 11/2017
1	ElementsIBA 11/2017
1	Phosphodiesterase InhibitorsIBA 11/2017
1	Proto-Oncogene Proteins c-pim-1 (Proto Oncogene Proteins c pim 1)IBA 07/2017
1	Adenosine Triphosphate (ATP)IBA 08/2016
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2015
1	Protein Kinases (Protein Kinase)IBA 11/2015
1	Adenosine Monophosphate (AMP)IBA 11/2015
1	BenzenesulfonamidesIBA 11/2015
1	TensinsIBA 11/2015
1	2,4-thiazolidinedione (thiazolidinedione)IBA 11/2015
1	CurcuminIBA 07/2015
1	Histone Deacetylases (Histone Deacetylase)IBA 12/2014
1	anilinoquinazolineIBA 04/2014
1	EstersIBA 05/2013

Therapy/Procedure

8	Therapeutics 12/2022 - 12/2017
1	Drug Therapy (Chemotherapy) 12/2020
1	Oral Administration 11/2019